UnitedHealth Group — Jul 16, 2026 release
Fiscal 2026 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000731766-26-000191
Showing in the filing
Prior approval volume elimination
“30%”
Period
FY2026
Measure
Company-defined measure
Source
Prose
All guidance in this release · 30
Earnings Outlook (Diluted EPS) for FY2026
“$18.45 to $18.95 Per Share”
Adjusted earnings outlook for FY2026
“$19.50 to $20.00 Per Share”
UnitedHealthcare - Reported Operating Earnings for FY2026
“> $12,000”
Optum Health - Reported Operating Earnings for FY2026
“> $2,275”
Optum Health - Adjusted Operating Earnings for FY2026
“> $2,215”
Optum Insight - Reported Operating Earnings for FY2026
“> $4,925”
Optum Rx - Reported Operating Earnings for FY2026
“> $6,250”
Optum (a) - Reported Operating Earnings for FY2026
“> $13,450”
UnitedHealth Group - Reported Operating Earn… for FY2026
“> $25,450”
UnitedHealth Group - Adjusted Operating Earn… for FY2026
“> $25,215”
Medical Care Ratio for FY2026
“88.1% ± 25 bps”
Net Earnings to UNH Shareholders for FY2026
“> $16,750”
Diluted Net Earnings per Share to UNH Shareh… for FY2026
“$18.45 - $18.95”
Doula care coverage eligible members for FY2027
“more than 7 million”
Prior approval volume elimination for FY2026
“30%”
Pediatric prior approval requirement elimina… for FY2026
“nearly two-thirds”
UnitedHealthcare prior approvals included in… for FY2026
“more than 70%”
Manufacturer drug rebate discount pass-throu… for FY2028
“100%”
Long-term debt-to-capital ratio target for the long term
“approximately 40.0%”
Share Repurchase for FY2026
“at least $5.0 billion”
Operating Earnings - UnitedHealthcare for FY2026
“> $10,800”
Operating Earnings - Optum Health for FY2026
“> $2,200”
Optum Insight - Adjusted Operating Earnings for FY2026
“> $4,750”
Operating Earnings - Optum for FY2026
“> $13,200”
Operating Earnings - UnitedHealth Group for FY2026
“> $24,000”
Adjusted Earnings per Share (1) for FY2026
“> $17.75”
Adjusted Net Earnings per Share (b) for FY2026
“$19.50 - $20.00”
Tax Rate for FY2026
“~19.25%”
Cash Flows from Operations for FY2026
“> $18,000”
Optum (a) - Adjusted Operating Earnings for FY2026
“> $13,215”
Exhibit 99.1 · the passage around this item
… earlier in the release
Prior Approval Reform The company is removing prior approval requirements, standardizing processes across the industry, cutting back on paperwork and increasing transparency into the prior approval process, making it quicker and simpler for doctors to treat patients. • Eliminating 30% of current prior approval volume by the end of 2026. • Eliminating nearly two-thirds of prior approval requirements for pediatric care, including waivers for certain procedures performed at leading pediatric hospitals by the end of 2026. • Leading an industry-wide effort to standardize prior approval requirements for electronic submissions, with more than 70% of UnitedHealthcare prior approvals expected to be included by the end of 2026. • Publicly reporting prior approval metrics to help care providers and the public better understand the process. • Expanding eligibility for UnitedHealthcare's Gold Card program – exempting high-performing providers from routine approval requirements entirely – and removing requirements for home health services, representing nearly 10% of total UHC prior approval volume. Pharmacy Reform and Drug Affordability To combat high prescription drug costs, the company is lowering out-of-pocket costs for patients and bringing greater transparency to pharmacy benefits, setting a new standard for the industry. • Launched the industry’s first fully transparent, fee-based pharmacy care model to bring greater clarity, predictability and affordability by decoupl
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.